Evexius Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.12 M
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 98.06%
- Profit Growth 0.54%
- Ebitda -0.77%
- Net Worth -5.37%
- Total Assets 150.22%
About Evexius
Evexius Private Limited (EPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 02 January 2018 (Seven years and one month 2 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.12 M, as per Ministry of Corporate Affairs (MCA) records.
Riyajahmed Desai, Dimple Das, Sanjay Joshi, and Three other members serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74995MH2018PTC303572
-
Company No.
303572
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Jan 2018
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Evexius?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Joshi
|
Director | 02-Jan-2018 | Current |
Maneesh Shrivastav
|
Director | 02-Jan-2018 | Current |
|
Riyajahmed Desai
|
Director | 12-Jun-2019 | Current |
|
Dimple Das
|
Director | 02-Jan-2018 | Current |
|
Bhargavi Sridhara
|
Director | 19-Oct-2021 | Current |
|
Debina Das
|
Director | 12-Jun-2019 | Current |
Financial Performance of Evexius.
Evexius Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 98.06% increase. The company also saw a slight improvement in profitability, with a 0.54% increase in profit. The company's net worth dipped by a decrease of 5.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Evexius?
In 2019, Evexius had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Innovant Healthcare Solutions LlpRiyajahmed Desai is a mutual person
-
Innovant Scientific Private Limited
Riyajahmed Desai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Evexius?
Unlock and access historical data on people associated with Evexius, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evexius, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evexius's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.